14th European Post-Chicago Melanoma / Skin Cancer Meeting
The first Post-Chicago Meeting on Melanoma / Skin Cancer took place 2011. In 2019, the meeting has attracted nearly 700 participants from 40 countries. In 2020 and 2021, the congress was held virtually due to the Covid pandemic. 2022 a hybrid event was implemented. In 2024 the congress will again be held as a hybrid conference.
The interactive meeting offers a comprehensive overview on all new developments in melanoma diagnostics and therapy and a direct communication with the world´s leading experts in these fields.
The aim of the interdisciplinary global conference on news in melanoma / skin cancer in Munich is to grant a deep overall insight into the development of new drugs for melanoma and other cutaneous malignancies. The lively interaction of clinicians, as well as experts in translational and basic research, and representatives of the pharmaceutical industry, guarantees a successful outcome for every participant.
International key opinion leaders on melanoma will be invited to give an overview throughout specified presentations, to present latest clinical trial results, and to discuss on exciting new drugs with the audience. In addition to the scientific value of this meeting, every participant may seize the given opportunity to interact with experts in a familiar setting in one of the most interesting cities of Germany.
Please join us for this event and submit your own studies and case presentations as free communications and as posters.
We look forward to welcoming you in Munich in 2024!
Axel Hauschild, MD Claus Garbe, MD
Congress Presidents
For complete information, please visit the dedicated website:
european-post-chicago-meeting.org
